STADA ARZNEIMITT. NA O.N. overview

DGAP-News: STADA Arzneimittel AG / Key word(s): Bond STADA Arzneimittel Aktiengesellschaft Announcement of the Results of the Tender Offer 21.06.2019 / 09:00 The issuer is solely responsible for the content of this announcement. NOT FOR DISTRIBUTION TO ANY U.S. PERSON OR IN OR INTO OR TO ANY PERSON LOCATED IN THE UNITED STATES. June 21, 2019 - STADA Arzneimittel Aktiengesellschaft (the " Offeror ") with its registered office at Stadastraße 2-18, 61118 Bad Vilbel, Federal Republic of Germany,...

DGAP-News: STADA Arzneimittel AG / Key word(s): Bond Upcoming Expiration of Tender Offer and Intention to Delist Notes 23.05.2019 / 11:23 The issuer is solely responsible for the content of this announcement. May 23, 2019 - STADA Arzneimittel Aktiengesellschaft (" STADA ") would like to remind all holders of its outstanding 1.750% Notes due 2022 (ISIN XS1213831362, Common Code 121383136, German Securities Code (WKN) A14KJP) (the " Notes ") that the final expiration time of its pending tender...

DGAP-News: STADA Arzneimittel AG / Key word(s): Bond STADA Arzneimittel Aktiengesellschaft Announcement of the Results of the Tender Offer 21.05.2019 / 09:00 The issuer is solely responsible for the content of this announcement. NOT FOR DISTRIBUTION TO ANY U.S. PERSON OR IN OR INTO OR TO ANY PERSON LOCATED IN THE UNITED STATES. May 21, 2019 - STADA Arzneimittel Aktiengesellschaft (the " Offeror ") with its registered office at Stadastraße 2-18, 61118 Bad Vilbel, Federal Republic of Germany,...

DGAP-News: STADA Arzneimittel AG / Key word(s): Bond STADA Arzneimittel Aktiengesellschaft Announcement of the Results of the Tender Offer 23.04.2019 / 09:00 The issuer is solely responsible for the content of this announcement. NOT FOR DISTRIBUTION TO ANY U.S. PERSON OR IN OR INTO OR TO ANY PERSON LOCATED IN THE UNITED STATES. April 23, 2019 - STADA Arzneimittel Aktiengesellschaft (the " Offeror ") with its registered office at Stadastraße 2-18, 61118 Bad Vilbel, Federal Republic of Germany,...

DGAP-News: STADA Arzneimittel AG / Key word(s): Bond STADA Arzneimittel AG: Announcement of the Results of the Tender Offer 21.03.2019 / 09:00 The issuer is solely responsible for the content of this announcement. NOT FOR DISTRIBUTION TO ANY U.S. PERSON OR IN OR INTO OR TO ANY PERSON LOCATED IN THE UNITED STATES. March 21, 2019 - STADA Arzneimittel Aktiengesellschaft (the " Offeror ") with its registered office at Stadastraße 2-18, 61118 Bad Vilbel, Federal Republic of Germany, hereby announces...

DGAP-News: STADA Arzneimittel AG / Key word(s): Bond STADA Arzneimittel Aktiengesellschaft Announcement of the Results of the Tender Offer 21.02.2019 / 10:56 The issuer is solely responsible for the content of this announcement. NOT FOR DISTRIBUTION TO ANY U.S. PERSON OR IN OR INTO OR TO ANY PERSON LOCATED IN THE UNITED STATES. February 21, 2019 - STADA Arzneimittel Aktiengesellschaft (the " Offeror ") with its registered office at Stadastraße 2-18, 61118 Bad Vilbel, Federal Republic of...

DGAP-News: STADA Arzneimittel AG / Key word(s): Bond STADA Arzneimittel Aktiengesellschaft Announcement of the Results of the Tender Offer 22.01.2019 / 09:00 The issuer is solely responsible for the content of this announcement. NOT FOR DISTRIBUTION TO ANY U.S. PERSON OR IN OR INTO OR TO ANY PERSON LOCATED IN THE UNITED STATES. January 22, 2019 - STADA Arzneimittel Aktiengesellschaft (the " Offeror ") with its registered office at Stadastraße 2-18, 61118 Bad Vilbel, Federal Republic of Germany,...

DGAP-News: STADA Arzneimittel AG / Key word(s): Miscellaneous STADA's EUR 300,000,000 1.75% Senior Notes due 2022 20.12.2018 / 18:37 The issuer is solely responsible for the content of this announcement. Bad Vilbel, December 20, 2018 - In accordance with STADA Arzneimittel AG's ( STADA ) prior ad hoc notification, dated November 13, 2018, STADA and certain of its significant subsidiaries have today (in line with the instruction received from its majority shareholder Nidda Healthcare GmbH ( Nidda...